缺铁性心肌病
The cardiomyopathy of iron deficiency.
作者信息
Hegde Nikita, Rich Michael W, Gayomali Charina
机构信息
Department of Medicine, Summa Health System and Northeastern Ohio Universities College of Medicine (NEOUCOM), Akron, Ohio 44304, USA.
出版信息
Tex Heart Inst J. 2006;33(3):340-4.
Abstract
Iron-deficiency anemia can have deleterious effects on the heart. Herein, we describe the effects of iron deficiency on the heart as corroborated with electrocardiography, radiology, echocardiography, and cardiac catheterization. We review the pathophysiology, clinical features, and management of iron-deficiency-induced cardiomyopathy.
摘要
缺铁性贫血可对心脏产生有害影响。在此，我们描述缺铁对心脏的影响，并通过心电图、放射学、超声心动图和心导管检查加以证实。我们回顾缺铁性心肌病的病理生理学、临床特征及治疗方法。
相似文献
1
The cardiomyopathy of iron deficiency.
Tex Heart Inst J. 2006;33(3):340-4.
2
Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Eur Heart J. 1999 Oct;20(19):1415-23. doi: 10.1053/euhj.1999.1633.
3
Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy.
Neuromuscul Disord. 2004 Nov;14(11):732-9. doi: 10.1016/j.nmd.2004.08.002.
4
Invited commentary.
Ann Thorac Surg. 2009 Sep;88(3):726. doi: 10.1016/j.athoracsur.2009.06.021.
5
Plasma brain natriuretic peptide in takotsubo cardiomyopathy.
QJM. 2004 Sep;97(9):599-607. doi: 10.1093/qjmed/hch094.
6
B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy.
Int J Cardiol. 2007 Jul 31;119(3):389-91. doi: 10.1016/j.ijcard.2006.07.163. Epub 2006 Oct 31.
7
Understanding "diastolic heart failure": the tip of the iceberg.
J Am Coll Cardiol. 2007 Feb 13;49(6):695-7. doi: 10.1016/j.jacc.2006.11.014. Epub 2007 Jan 26.
8
The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
J Cardiovasc Pharmacol. 2007 Jun;49(6):408-15. doi: 10.1097/FJC.0b013e3180544540.
9
10
Relationship of natriuretic peptide and transthoracic echocardiographic findings in 135 subjects with muscular dystrophy.
Int J Cardiol. 2010 Dec 3;145(3):506-14. doi: 10.1016/j.ijcard.2009.12.018. Epub 2010 Jan 12.
引用本文的文献
1
From Gut Inflammation to Cardiovascular Conflagration: Mapping IBD's Cardiometabolic Risks.
Curr Atheroscler Rep. 2025 Sep 10;27(1):89. doi: 10.1007/s11883-025-01329-4.
2
Dietary Iron Supplementation Protects Against Growth Restriction and Metabolic Dysfunction-Associated Steatotic Liver Disease in Perinatal Cadmium-Exposed Mice.
FASEB Bioadv. 2025 Jun 17;7(8):e70027. doi: 10.1096/fba.2025-00045. eCollection 2025 Aug.
3
Hemodynamically significant anemia as an indication of transfusion in preterm infants.
Ital J Pediatr. 2025 May 16;51(1):140. doi: 10.1186/s13052-025-01978-w.
4
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry.
J Cardiovasc Dev Dis. 2025 Mar 16;12(3):103. doi: 10.3390/jcdd12030103.
5
Malnutrition-related cardiomyopathy in a pediatric patient with autism spectrum disorder.
JPGN Rep. 2024 Oct 25;6(1):39-42. doi: 10.1002/jpr3.12142. eCollection 2025 Feb.
6
The Intersection of Heart Failure and Iron Deficiency Anemia: Diagnostic and Therapeutic Approaches.
Curr Cardiol Rev. 2025;21(3):30-43. doi: 10.2174/011573403X331380241111091452.
7
An urgent appeal to paediatric primary caregivers to help prevent severe iron deficiency anemia in toddlers.
Paediatr Child Health. 2023 Mar 22;29(4):209-210. doi: 10.1093/pch/pxac089. eCollection 2024 Jul.
8
Dilated Cardiomyopathy Due to Alimentary Iron Deficiency.
Children (Basel). 2024 Feb 4;11(2):196. doi: 10.3390/children11020196.
9
Myocardial function using two dimension speckle-tracking echocardiography in children with celiac disease.
Eur J Pediatr. 2024 Feb;183(2):947-954. doi: 10.1007/s00431-023-05343-z. Epub 2023 Dec 7.
10
Correlation Between Anemia (Hemoglobin Level) and Cardiomegaly Based On Chest Radiograph and Echocardiography.
Acta Inform Med. 2023;31(3):191-194. doi: 10.5455/aim.2023.31.191-194.
本文引用的文献
1
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.
Circulation. 2005 Aug 23;112(8):1121-7. doi: 10.1161/CIRCULATIONAHA.104.512988. Epub 2005 Aug 15.
2
Blood haemoglobin is an independent predictor of B-type natriuretic peptide (BNP).
Clin Sci (Lond). 2005 Jul;109(1):69-74. doi: 10.1042/CS20040349.
3
Haemoglobin level influences plasma brain natriuretic peptide concentration.
Acta Cardiol. 2004 Oct;59(5):527-31. doi: 10.2143/AC.59.5.2005228.
4
Atrial natriuretic peptide in aged patients with iron deficiency anemia.
Arch Gerontol Geriatr. 1999 Mar-Apr;28(2):105-15. doi: 10.1016/s0167-4943(98)00131-9.
5
Relation of anemia to diastolic heart failure and the effect on outcome.
Am J Cardiol. 2004 Apr 15;93(8):1055-7. doi: 10.1016/j.amjcard.2003.12.062.
6
Myocardial infarction in a patient with beta-thalassemia major: first report.
Am J Hematol. 2004 Jan;75(1):52-5. doi: 10.1002/ajh.10454.
7
The cardio-renal anaemia syndrome: does it exist?
Nephrol Dial Transplant. 2003 Nov;18 Suppl 8:viii7-12. doi: 10.1093/ndt/gfg1084.
8
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
Circulation. 2003 Oct 28;108(17):2154-69. doi: 10.1161/01.CIR.0000095676.90936.80.
9
Anemia as a risk factor for cardiovascular disease.
Kidney Int Suppl. 2003 Nov(87):S32-9. doi: 10.1046/j.1523-1755.64.s87.6.x.
10
Iron deficiency--United States, 1999-2000.
MMWR Morb Mortal Wkly Rep. 2002 Oct 11;51(40):897-9.
Zotero 插件